BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/27/2018 9:38:46 AM | Browse: 278 | Download: 179
Publication Name World Journal of Hepatology
Manuscript ID 40193
Country/Territory Iran
2018-06-07 00:28
Peer-Review Started
2018-06-07 09:17
To Make the First Decision
2018-07-12 00:23
Return for Revision
2018-07-12 07:15
2018-07-19 11:32
Second Decision
2018-08-02 10:56
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2018-08-04 20:31
Articles in Press
2018-08-04 20:31
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2018-09-25 03:22
Publish the Manuscript Online
2018-09-27 09:38
ISSN 1948-5182 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Editorial
Article Title Hepatitis C resistance to NS5A inhibitors: Is it going to be a problem?
Manuscript Source Invited Manuscript
All Author List Heidar Sharafi and Seyed Moayed Alavian
Author(s) ORCID Number
Heidar Sharafi http://orcid.org/0000-0001-9177-9117
Seyed Moayed Alavian http://orcid.org/0000-0002-4443-6602
Funding Agency and Grant Number
Corresponding author Heidar Sharafi, BSc, MA, MPhil, MSc, PhD, Research Scientist, Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran 1415513651, Iran. h.sharafi@meldcenter.com
Keywords Direct-acting antiviral agent; Hepatitis C; NS5A; Resistance; Treatment
Core Tip Hepatitis C virus resistance to NS5A inhibitors is one of the main problems of treatment with NS5A inhibitors. While the treatment of NS5A inhibitor-naïve patients is feasible and efficient, retreatment of NS5A inhibitor-experienced patients is challenging. In the con­text of failure following treatment with NS5A inhibitor-containing regimens, NS5A resistance-associated subs­titution testing can help in clinical decision-making, while the usefulness of baseline NS5A resistance-associated substitution testing in NS5A inhibitor-naïve patients is in question.
Publish Date 2018-09-27 09:38
Citation Sharafi H, Alavian SM. Hepatitis C resistance to NS5A inhibitors: Is it going to be a problem? World J Hepatol 2018; 10(9): 543-548
Url http://www.wjgnet.com/1948-5182/full/v10/i9/543.htm
DOI http://dx.doi.org/10.4254/wjh.v10.i9.543
Full Article (PDF) WJH-10-543.pdf
Full Article (Word) WJH-10-543.doc
Manuscript File 40193-Review.docx
Answering Reviewers 40193-Answering reviewers.pdf
Audio Core Tip 40193-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 40193-Conflict-of-interest statement.pdf
Copyright License Agreement 40193-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 40193-Language certificate.pdf
Peer-review Report 40193-Peer-review(s).pdf
Scientific Misconduct Check 40193-Scientific misconduct check.pdf
Scientific Editor Work List 40193-Scientific editor work list.pdf